Diagnostic criteria for testing for BRCA1 and BRCA2: The experience of the Department of Defense Familial Breast/Ovarian Cancer Research Project

Military Medicine

Volumn 167, Issue 2, 2002, Pages 99-103

  Fries, Melissa H ^a   Holt, Charlene ^a   Carpenter, Isabelle ^a   Carter, Cindy L ^a   Daniels, Jamelyn ^a   Flanagan, Judith ^a   Murphy, Kay ^a   Hailey, B Jo ^a   Martin, Laura ^a   Hume, Roderick ^a   Hudson, Gracia ^a   Cadman, Mary ^a   Weatherly, Ronald ^a   Nunes, Mark E ^a  

^a USAF Medical Center Keesler   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MODEL; CANCER RISK; DISEASE PREDISPOSITION; DNA DETERMINATION; FAMILIAL CANCER; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; MISSENSE MUTATION; NONSENSE MUTATION; ONSET AGE; OUTCOMES RESEARCH; OVARY CANCER; RISK ASSESSMENT; SCORING SYSTEM; STATISTICS;

EID: 0036176097     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/167.2.99     Document Type: Article

References (17)

1. Inherited predisposition to breast and ovarian cancer
2. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
3. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
4. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population
5. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: Results from three U.S. population-based case-control studies of ovarian cancer
6. Autosomal dominant inheritance of earlyonset breast cancer
7. A collaborative study of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening
8. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
9. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
10. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
11. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer
12. BRCA1 mutations in African Americans
13. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer
14. Mutation analysis of BRCA1 and BRCA2 in Turkish cancer families: A novel mutation BRCA2 3414del4 found in male breast cancer
15. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
16. Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA
17. Frequency of BRCA1 mutation 5382insC in German breast cancer patients